Yes, methimazole can be safely taken while breastfeeding and is actually the preferred antithyroid drug for nursing mothers.
Methimazole is the recommended antithyroid medication for lactating women with hyperthyroidism, even at doses up to 20-30 mg daily. 1 This represents a significant shift from older practices that favored propylthiouracil (PTU) during breastfeeding.
Why Methimazole is Preferred During Lactation
The key reason for this preference is safety concerns about propylthiouracil causing potentially fatal hepatotoxicity in either the mother or infant 1. While PTU was historically favored because it transfers into breast milk in smaller amounts (0.025%) 2, the risk of severe, idiosyncratic liver failure—which can require transplantation or result in death—has changed clinical practice.
Evidence Supporting Safety
The FDA drug label explicitly states that "several studies found no effect on clinical status in nursing infants of mothers taking methimazole" and references "a long-term study of 139 thyrotoxic lactating mothers and their infants [that] failed to demonstrate toxicity" 3.
Multiple research studies reinforce this safety profile:
- Studies of infants breastfed by mothers taking 20-30 mg daily of methimazole showed normal thyroid function (T4, T3, TSH) throughout 12 months of maternal treatment 4, 5
- Long-term follow-up (ages 4-7 years) demonstrated normal intellectual development with IQ scores of 103-107, comparable to control children 6
- Serum methimazole levels in breastfed infants were minimal (<0.03-0.035 mcg/mL), even when mothers were hypothyroid from treatment 4, 5
Practical Management Approach
Dosing considerations:
- Doses up to 30 mg daily during the first month are safe
- Maintenance doses of 5-10 mg daily are typical after initial control
- No need to interrupt breastfeeding or "pump and dump"
Monitoring requirements: The FDA recommends monitoring infant thyroid function at frequent (weekly or biweekly) intervals 3, though research studies showed this was largely precautionary as no thyroid dysfunction occurred in practice.
Important caveat: While methimazole is present in breast milk (unlike T4/T3 which cross minimally), the amounts transferred are not clinically significant for the infant 1.
Clinical Algorithm
- If starting antithyroid therapy postpartum: Use methimazole (not PTU)
- If already on PTU from pregnancy: Switch to methimazole after delivery for breastfeeding
- Dose: Start 10-30 mg daily based on hyperthyroidism severity
- Monitor: Maternal thyroid function monthly; consider infant thyroid screening if concerned
- Reassure: Breastfeeding benefits outweigh theoretical minimal risks 7
The 2011 American Thyroid Association/American Association of Clinical Endocrinologists guidelines are unequivocal on this point, making methimazole the clear choice for nursing mothers requiring antithyroid treatment 1.